Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

NCT05019690 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

29

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Triple Negative Breast Cancer

Interventions

DRUG: Apatinib Mesylate
DRUG: Albumin-Bound Paclitaxel

Sponsor

Fujian Cancer Hospital